Mechanical circulatory support for heart failure: Past, present and a look at the future

Expert Review of Medical Devices

Volumn 10, Issue 1, 2013, Pages 55-71

  Moazami, Nader ^a   Hoercher, Katherine J ^a   Fukamachi, Kiyotaka ^a   Kobayashi, Mariko ^a   Smedira, Nicholas G ^a   Massiello, Alex ^a   Horvath, David J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

circulation; heart; heart failure; heart transplantation; heart assist devices; pumps

Indexed keywords

GOLD STANDARDS; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; MANAGEMENT STRATEGIES; MECHANICAL CIRCULATORY SUPPORT;

BOILER CIRCULATION; HEART; PATIENT TREATMENT; PUMPS;

CARDIOLOGY;

ARTERIAL PRESSURE; ARTIFICIAL HEART; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; COGNITION; DISEASE EXACERBATION; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; LIFE SUPPORT EQUIPMENT; MECHANICAL CIRCULATORY SUPPORT; PATIENT CODING; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT SELECTION; REVIEW; RIGHT VENTRICULAR ASSIST DEVICE; THROMBOEMBOLISM; THROMBOSIS;

EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FORECASTING; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; THERAPY, COMPUTER-ASSISTED;

EID: 84871994235     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.12.69     Document Type: Review

References (83)

1. Copeland JG, Smith RG, Arabia FA et al.; CardioWest Total Artificial Heart Investigators. Cardiac replacement with a total artificial heart as a bridge to transplantation. N. Engl. J. Med. 351(9), 859-867 (2004). (Pubitemid 39099324)
2. Smedira NG, Hoercher KJ, Yoon DY et al. Bridge to transplant experience: Factors influencing survival to and after cardiac transplant. J. Thorac. Cardiovasc. Surg. 139(5), 1295-1305, 1305.e1 (2010).
3. Nativi JN, Drakos SG, Kucheryavaya AY et al. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: An analysis of the registry of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 30(8), 854-861 (2011).
4. Navia JL, McCarthy PM, Hoercher KJ et al. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann. Thorac. Surg. 74(6), 2051-2062; discussion 2062 (2002).
5. Cleveland JC Jr, Grover FL, Fullerton DA et al. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival. J. Thorac. Cardiovasc. Surg. 136(3), 774-777 (2008).
6. Rose EA, Gelijns AC, Moskowitz AJ et al.; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N. Engl. J. Med. 345(20), 1435-1443 (2001).
7. Kirklin JK, Naftel DC, Pagani FD et al. Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? J. Thorac. Cardiovasc. Surg. 144(3), 584-603; discussion 597 (2012).
8. Sheikh FH, Russell SD. HeartMate® II continuous-flow left ventricular assist system. Expert Rev. Med. Devices 8(1), 11-21 (2011).
9. Krishnamani R, DeNofrio D, Konstam MA. Emerging ventricular assist devices for long-term cardiac support. Nat. Rev. Cardiol. 7(2), 71-76 (2010).
10. Letsou GV, Myers TJ, Gregoric ID et al. Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months. Ann. Thorac. Surg. 76(4), 1167-1170 (2003). (Pubitemid 37204727)
11. Noon GP, Morley DL, Irwin S, Abdelsayed SV, Benkowski RJ, Lynch BE. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann. Thorac. Surg. 71(3 Suppl), S133-S138; discussion S144 (2001). (Pubitemid 32216203)
12. Larose JA, Tamez D, Ashenuga M, Reyes C. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J. 56(4), 285-289 (2010).
13. Morshuis M, Schoenbrodt M, Nojiri C et al. DuraHeart magnetically levitated centrifugal left ventricular assist system for advanced heart failure patients. Expert Rev. Med. Devices 7(2), 173-183 (2010).
14. Miller LW, Pagani FD, Russell SD et al.; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 357(9), 885-896 (2007). (Pubitemid 47347322)
15. Pagani FD, Miller LW, Russell SD et al.; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J. Am. Coll. Cardiol. 54(4), 312-321 (2009).
16. John R, Pagani FD, Naka Y et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables. J. Thorac. Cardiovasc. Surg. 140(1), 174-181 (2010).
17. John R, Naka Y, Smedira NG et al. Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. Ann. Thorac. Surg. 92(4), 1406-1413; discussion 1413 (2011).
18. Starling RC, Naka Y, Boyle AJ et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J. Am. Coll. Cardiol. 57(19), 1890-1898 (2011).
19. Slaughter MS, Rogers JG, Milano CA et al.; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 361(23), 2241-2251 (2009).
20. Kirklin JK, Naftel DC, Kormos RL et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J. Heart Lung Transplant. 31(2), 117-126 (2012).
21. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: The REVIVE-IT pilot trial. J. Card. Fail. 16(11), 855-858 (2010).
22. Cowger J, Pagani FD, Haft JW, Romano MA, Aaronson KD, Kolias TJ. The development of aortic insufficiency in left ventricular assist device-supported patients. Circ. Heart Fail. 3(6), 668-674 (2010).
23. Soleimani B, Haouzi A, Manoskey A, Stephenson ER, El-Banayosy A, Pae WE. Development of aortic insufficiency in patients supported with continuous flow left ventricular assist devices. ASAIO J. 58(4), 326-329 (2012).
24. Slaughter MS, Pagani FD, Rogers JG et al.; HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J. Heart Lung Transplant. 29(Suppl. 4), S1-S39 (2010).
25. Rossi M, Serraino GF, Jiritano F, Renzulli A. What is the optimal anticoagulation in patients with a left ventricular assist device? Interact. Cardiovasc. Thorac. Surg. 15(4), 733-740 (2012).
26. Aissaoui N, Börgermann J, Gummert J, Morshuis M. HeartWare continuous-flow ventricular assist device thrombosis: The Bad Oeynhausen experience. J. Thorac. Cardiovasc. Surg. 143(4), e37-e39 (2012).
27. Rothenburger M, Wilhelm MJ, Hammel D et al. Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 106(12 Suppl. 1), I189-I192 (2002).
28. Hayes H, Dembo L, Larbalestier R, O'Driscoll G. Successful treatment of ventricular assist device associated ventricular thrombus with systemic tenecteplase. Heart. Lung Circ. 17(3), 253-255 (2008). (Pubitemid 351635991)
29. Kiernan MS, Pham DT, DeNofrio D, Kapur NK. Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J. Thorac. Cardiovasc. Surg. 142(3), 712-714 (2011).
30. Kamouh A, John R, Eckman P. Successful treatment of early thrombosis of Heart-Ware left ventricular assist device with intraventricular thrombolytics. Ann. Thorac. Surg. 94(1), 281-283 (2012).
31. Delgado R 3rd, Frazier OH, Myers TJ et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J. Heart Lung Transplant. 24(2), 231-233 (2005). (Pubitemid 40215604)
32. Thomas MD, Wood C, Lovett M, Dembo L, O'Driscoll G. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J. Heart Lung Transplant. 27(8), 925-927 (2008). (Pubitemid 352024419)
33. Meyer AL, Kuehn C, Weidemann J et al. Thrombus formation in a HeartMate II left ventricular assist device. J. Thorac. Cardiovasc. Surg. 135(1), 203-204 (2008).
34. Chumnanvej S, Wood MJ, MacGillivray TE, Melo MF. Perioperative echocardiographic examination for ventricular assist device implantation. Anesth. Analg. 105(3), 583-601 (2007). (Pubitemid 47300829)
35. Estep JD, Stainback RF, Little SH, Torre G, Zoghbi WA. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. JACC. Cardiovasc. Imaging 3(10), 1049-1064 (2010).
36. Raman SV, Sahu A, Merchant AZ, Louis LB 4th, Firstenberg MS, Sun B. Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. J. Heart Lung Transplant. 29(1), 79-85 (2010).
37. Eckman PM, John R. Bleeding and thrombosis in patients with continuousflow ventricular assist devices. Circulation 125(24), 3038-3047 (2012).
38. Crow S, Chen D, Milano C et al. Acquired von Willebrand syndrome in continuousflow ventricular assist device recipients. Ann. Thorac. Surg. 90(4), 1263-1269; discussion 1269 (2010).
39. Demirozu ZT, Radovancevic R, Hochman LF et al. Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J. Heart Lung Transplant. 30(8), 849-853 (2011).
40. Hannan MM, Husain S, Mattner F et al.; International Society for Heart and Lung Transplantation. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J. Heart Lung Transplant. 30(4), 375-384 (2011).
41. Schulman AR, Martens TP, Christos PJ et al. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J. Thorac. Cardiovasc. Surg. 133(3), 841-842 (2007). (Pubitemid 46274760)
42. Cesario DA, Saxon LA, Cao MK, Bowdish M, Cunningham M. Ventricular tachycardia in the era of ventricular assist devices. J. Cardiovasc. Electrophysiol. 22(3), 359-363 (2011).
43. Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. J. Heart Lung Transplant. 26(8), 819-825 (2007). (Pubitemid 47199071)
44. Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin. Electrophysiol. 31(10), 1246-1252 (2008).
45. Oswald H, Schultz-Wildelau C, Gardiwal A et al. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur. J. Heart Fail. 12(6), 593-599 (2010).
46. Ochiai Y, McCarthy PM, Smedira NG et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients. Circulation 106(12 Suppl. 1), I198-I202 (2002).
47. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J. Am. Coll. Cardiol. 51(22), 2163-2172 (2008). (Pubitemid 351713685)
48. Hall JL, Fermin DR, Birks EJ et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J. Am. Coll. Cardiol. 57(6), 641-652 (2011).
49. Birks EJ, Tansley PD, Hardy J et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N. Engl. J. Med. 355(18), 1873-1884 (2006). (Pubitemid 44664645)
50. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur. Heart J. 22(7), 534-540 (2001). (Pubitemid 32625243)
51. Aaronson KD, Pagani FD, Maybaum SW et al. 3 combination therapy with pulsatile left ventricular assist device, heart failure medication and clenbuterol in chronic heart failure: Results from HARPS [abstract]. J. Heart Lung Transplant. 30(4), S8-S9 (2011).
52. Drakos SG, Kfoury AG, Stehlik J et al. Bridge to recovery: Understanding the disconnect between clinical and biological outcomes. Circulation 126(2), 230-241 (2012).
53. Birks EJ, George RS, Hedger M et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: A prospective study. Circulation 123(4), 381-390 (2011).
54. Krabatsch T, Schweiger M, Dandel M et al. Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann. Thorac. Surg. 91(5), 1335-1340 (2011).
55. Farrar DJ, Bourque K, Dague CP, Cotter CJ, Poirier VL. Design features, developmental status, and experimental results with the HeartMate III centrifugal left ventricular assist system with a magnetically levitated rotor. ASAIO J. 53(3), 310-315 (2007). (Pubitemid 46791537)
56. Slaughter MS, Sobieski MA 2nd, Tamez D et al. HeartWare miniature axial-flow ventricular assist device: Design and initial feasibility test. Tex. Heart Inst. J. 36(1), 12-16 (2009).
57. Klotz S, Meyns B, Simon A et al. Partial mechanical long-term support with the CircuLite Synergy pump as bridge-totransplant in congestive heart failure. Thorac. Cardiovasc. Surg. 58(Suppl. 2), S173-S178 (2010).
58. Raess DH, Weber DM. Impella 2.5. J. Cardiovasc. Transl. Res. 2(2), 168-172 (2009).
59. Meyns BP, Simon A, Klotz S et al. Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and Early Class IV patients. Eur. J. Cardiothorac. Surg. 39(5), 693-698 (2011).
60. Loforte A, Monica PL, Montalto A, Musumeci F. HeartWare third-generation implantable continuous flow pump as biventricular support: Mid-term follow-up. Interact. Cardiovasc. Thorac. Surg. 12(3), 458-460 (2011).
61. Strueber M, Meyer AL, Malehsa D, Haverich A. Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J. Thorac. Cardiovasc. Surg. 140(4), 936-937 (2010).
62. Hetzer R, Krabatsch T, Stepanenko A, Hennig E, Potapov EV. Long-term biventricular support with the heartware implantable continuous flow pump. J. Heart Lung Transplant. 29(7), 822-824 (2010).
63. Frazier OH, Myers TJ, Gregoric I. Biventricular assistance with the Jarvik FlowMaker: A case report. J. Thorac. Cardiovasc. Surg. 128(4), 625-626 (2004). (Pubitemid 39278402)
64. Loebe M, Bruckner B, Reardon MJ et al. Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc. J. 7(1), 40-44 (2011).
65. Frazier OH, Tuzun E, Cohn WE, Conger JL, Kadipasaoglu KA. Total heart replacement using dual intracorporeal continuous-flow pumps in a chronic bovine model: A feasibility study. ASAIO J. 52(2), 145-149 (2006). (Pubitemid 44309496)
66. Nonaka K, Linneweber J, Ichikawa S et al. Development of the Baylor Gyro permanently implantable centrifugal blood pump as a biventricular assist device. Artif. Organs 25(9), 675-682 (2001). (Pubitemid 33064435)
67. Olegario PS, Yoshizawa M, Tanaka A et al. Outflow control for avoiding atrial suction in a continuous flow total artificial heart. Artif. Organs 27(1), 92-98 (2003). (Pubitemid 36114849)
68. Strueber M, Schmitto JD, Kutschka I, Haverich A. Placement of 2 implantable centrifugal pumps to serve as a total artificial heart after cardiectomy. J. Thorac. Cardiovasc. Surg. 143(2), 507-509 (2012).
69. Fumoto H, Horvath DJ, Rao S et al. In vivo acute performance of the Cleveland Clinic self-regulating, continuous-flow total artificial heart. J. Heart Lung Transplant. 29(1), 21-26 (2010).
70. Fukamachi K, Horvath DJ, Massiello AL et al. An innovative, sensorless, pulsatile, continuous-flow total artificial heart: Device design and initial in vitro study. J. Heart Lung Transplant. 29(1), 13-20 (2010).
71. Timms D, Fraser J, Hayne M, Dunning J, McNeil K, Pearcy M. The BiVACOR rotary biventricular assist device: Concept and in vitro investigation. Artif. Organs 32(10), 816-819 (2008).
72. Kormos RL, Teuteberg JJ, Pagani FD et al.; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J. Thorac. Cardiovasc. Surg. 139(5), 1316-1324 (2010).
73. Drakos SG, Janicki L, Horne BD et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am. J. Cardiol. 105(7), 1030-1035 (2010).
74. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J. Heart Lung Transplant. 28(9), 971-976 (2009).
75. Fukamachi K, Shiose A, Massiello AL et al. Implantable continuous-flow right ventricular assist device: Lessons learned in the development of a cleveland clinic device. Ann. Thorac. Surg. 93(5), 1746-1752 (2012).
76. Saito S, Sakaguchi T, Miyagawa S et al. Biventricular support using implantable continuous-flow ventricular assist devices. J. Heart Lung Transplant. 30(4), 475-478 (2011).
77. Takagaki M, Wurzer C, Wade R et al. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE. Ann. Thorac. Surg. 86(5), 1677-1679 (2008).
78. Potapov E, Schweiger M, Vierecke J et al. Discontinuation of HeartWare RVAD support without device removal in chronic BIVAD patients. ASAIO J. 58(1), 15-18 (2012).
79. Mehta SM, Pae WE Jr, Rosenberg G et al. The LionHeart LVD-2000: A completely implanted left ventricular assist device for chronic circulatory support. Ann. Thorac. Surg. 71(Suppl. 3), S156-S161; discussion S183 (2001). (Pubitemid 32216208)
80. Dowling RD, Gray LA Jr, Etoch SW et al. The AbioCor implantable replacement heart. Ann. Thorac. Surg. 75(Suppl. 6), S93-S99 (2003). (Pubitemid 36677195)
81. Westaby S, Jarvik R, Freeland A et al. Postauricular percutaneous power delivery for permanent mechanical circulatory support. J. Thorac. Cardiovasc. Surg. 123(5), 977-983 (2002).
82. Burri H, Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators. Europace 11(6), 701-709 (2009).
83. Jung W, Rillig A, Birkemeyer R, Miljak T, Meyerfeldt U. Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems. J. Interv. Card. Electrophysiol. 23(1), 73-85 (2008).